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IntroductIon
Heparan sulfate (HS) is a sulfated linear polysaccharide con-
sisting of repeating disaccharide units of either glucuronic or 
iduronic acid, alternating with N-acetyl-glucosamine. HS is 
heterogeneously sulfated at the N, 6-O, and 3-O positions of 
glucosamine and at the 2-O position of uronic acids. All HS 
in vivo is found covalently bound to specific core proteins as 
HS proteoglycans (HSPGs; Reichsman et al., 1996; Stewart 
and Sanderson, 2014; Ortmann et al., 2015). HSPGs bind to 
and regulate the activity of morphogens that provide timed 
We studied three patients with severe skeletal dysplasia, t cell immunodeficiency, and developmental delay. Whole-exome 
sequencing revealed homozygous missense mutations affecting exostosin-like 3 (EXtL3), a glycosyltransferase involved in 
heparan sulfate (HS) biosynthesis. Patient-derived fibroblasts showed abnormal HS composition and altered fibroblast growth 
factor 2 signaling, which was rescued by overexpression of wild-type EXtL3 cdnA. Interleukin-2–mediated StAt5 
phosphorylation in patients’ lymphocytes was markedly reduced. Interbreeding of the extl3-mutant zebrafish (box) with 
tg(rag2 :green fluorescent protein) transgenic zebrafish revealed defective thymopoiesis, which was rescued by injection of 
wild-type human EXtL3 rnA. targeted differentiation of patient-derived induced pluripotent stem cells showed a reduced 
expansion of lymphohematopoietic progenitor cells and defects of thymic epithelial progenitor cell differentiation. these data 
identify EXtL3 mutations as a novel cause of severe immune deficiency with skeletal dysplasia and developmental delay and 
underline a crucial role of HS in thymopoiesis and skeletal and brain development.
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and spatially regulated developmental cues that control skel-
etal patterning (Revest et al., 2001a), thymus organogenesis 
(Rodewald, 2008), thymic epithelial cell (TEC) differentia-
tion (Dooley et al., 2007; Saldaña et al., 2016), and lympho-
poiesis (Borghesi et al., 1999).
The exostosin (EXT) family of genes encodes glycosyl-
transferases involved in the initiation of HS biosynthesis and 
elongation of HS chains (Esko and Lindahl, 2001; Busse et 
al., 2007). Conditional deletion of the Ext1 gene from limb 
mesenchyme causes skeletal defects with shortening of long 
bones in mice (Matsumoto et al., 2010), and both dak and 
box zebrafish (with mutations in the ext2 and in the EXT-
like 3 [extl3] genes, respectively) show defects of pectoral fin 
and branchial arch development (Schilling et al., 1996; van 
Eeden et al., 1996; Norton et al., 2005).
Primary immunodeficiencies include over 300 distinct 
disorders (Picard et al., 2015), and genetic disorders of the 
skeleton include over 450 disorders (Bonafe et al., 2015). 
A small number of disorders exist that combine a skeletal dys-
plasia with immune dysfunction of variable severity. Among 
these, the best-defined entities are cartilage-hair hypoplasia, 
Schimke immuno-osseous dysplasia, and spondyloenchon-
dromatosis, but other conditions have been described (Gatti et 
al., 1969; MacDermot et al., 1991; Schofer et al., 1991; Corder 
et al., 1995; Castriota-Scanderbeg et al., 1997; Clewing et al., 
2007) whose molecular bases have remained elusive so far.
Here, we report biallelic EXTL3 mutations in three pa-
tients from two families with severe T cell immunodeficiency, 
skeletal dysplasia, and neurodevelopmental delay and provide 
evidence for a critical role of HS in human thymopoiesis 
and skeletal development.
rESuLtS And dIScuSSIon
clinical phenotype and imaging studies
We studied three patients from two families who presented 
at birth with short-limb skeletal dysplasia and severe T cell 
immunodeficiency (Fig.  1 and the Case studies section of 
Materials and methods). Skeletal radiography revealed similar 
abnormalities at birth in all three patients (Fig.1, D–L) consist-
ing of: generalized platyspondyly with increased interverte-
bral space, narrow sacro-ischiatic notches with trident-shaped 
acetabula, and short and plump limb bones, metacarpals, and 
phalanges. Premature craniosynostosis was seen in the skull 
x ray and computed tomography studies of patient 1 (P1) and 
P2, with cloverleaf deformity in P2. All three patients had 
narrowing of the cervical canal, and severe narrowing of the 
laryngotracheal tract was present in P1 and P2. Neurological 
abnormalities included: opisthotonus, hyperreflexia, gener-
alized seizures, and developmental delay in P1; clonic arm 
movements, nystagmus, and developmental arrest in P2; and 
muscular hypotonia and marked developmental delay in P3.
Immunological studies
P2 and P3 manifested in the first month of life a T− B+ NK+ 
SCID phenotype, which in P3 was ascertained after posi-
tive newborn screening for SCID (Fig. 1 M). The presence 
of autologous, activated, and oligoclonal T cells, associated 
with generalized exfoliative dermatitis suggestive of Omenn 
syndrome, was documented in P1 (Fig. 1 A). Impaired pro-
liferation to mitogens and eosinophilia was documented in 
all three infants. Hypogammaglobulinemia but increased 
IgE serum levels were detected in P1 and P2. At 1 yr and 
4 mo of age, partial recovery of T cell count and function was 
documented in P3, who has mounted antibody responses to 
killed and live vaccines.
Genetic analysis
As the radiographical findings at birth were reminiscent of fi-
broblast growth factor (FGF) receptor 3 (FGFR3)–associated 
dysplasias and craniosynostosis and laryngeal narrowing are 
associated with FGFR1 and FGFR2 mutations (Hockstein et 
al., 2004), we sequenced FGFR1, FGFR2, and FGFR3 genes, 
but no mutations were identified. The notion that the parents 
of P1 and P2 were from the same village, together with the 
rarity of the condition, led us to assume autosomal recessive 
inheritance with consanguinity by descent as a probable ge-
netic basis of the disease in family 1. Whole-exome sequenc-
ing (WES) revealed three small regions of homozygosity on 
chromosomes 4, 6, and 8 in P1 and P2 but not in their par-
ents. Upon filtering (Fig. S1), only four genes (FCG BP, HEA 
TR5A, MIC AL3, and EXTL3) carried variants that were 
compatible with mutations causing a rare, recessively inher-
ited disease in this family (Tables S1 and S2). WES was also 
performed in P3 and in her parents. Upon filtering (Fig. S1), 
one de novo heterozygous variant, four homozygous vari-
ants, and eight compound heterozygous variants in four genes 
were detected in P3 (Tables S1 and S2).
EXTL3 was the only gene in which biallelic variants 
were identified in P1 and P2 (c.1015C>T; p.R339W), as well 
as in P3 (c.1382C>T; p.P461L; Fig. 1 N), whereas the respec-
tive parents were heterozygous for the same mutations. The 
identification of mutations in the same gene in both families 
sharing a similar phenotype makes EXTL3 a strong candidate 
gene. To further support this hypothesis: (a) the p.R339W 
variant is not reported in public or private databases, and the 
p.P461L variant is reported at very low frequency in Exome 
Aggregation Consortium database (Tables S1 and S2); (b) 
both mutations affect highly conserved residues (Fig.  1 O) 
and are predicted to be deleterious by Polyphen2, pMUT, 
Sorting Intolerant From Tolerant (SIFT), Mutation taster, 
Synonymous Non-synonymous Analysis Program (SNAP), 
SNP, and Gene Ontology databases; (c) their combined an-
notation-dependent depletion Phred score (17.64 for the 
p.R339W mutation and 15.4 for the p.P461L mutation) is 
significantly higher than the mutation significance cut off 
(Itan et al., 2016), which for the EXTL3 gene is 8.931; and 
(d) defects of skeletal development had been previously re-
ported in the boxtm70g zebrafish carrying a hypomorphic 
(D831N) extl3 mutation (Schilling et al., 1996; van Eeden et 
al., 1996; Lee et al., 2004).
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Figure 1. clinical and immunological phenotype and mutation analysis. (A–C) Clinical image of P1 (showing exfoliative erythroderma) at 9 mo of age 
(A), cloverleaf skull and bulging fontanelle in P2 at age 2 mo (B), and P3 at age 2 yr and 6 mo showing a moderately bulging forehead and sunken nasal 
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the EXtL3 r339W mutation causes 
abnormalities of HS production
Western blotting showed similar levels of EXTL3 protein ex-
pression in fibroblasts from P1 and a healthy control and in 
PBMCs from P3 and a healthy donor (Fig. 2 A). P1- and con-
trol-derived fibroblasts produced equivalent amount of HS 
(0.131 and 0.117 µg/106 cells, respectively). However, longer 
HS chains in the patient sample were detected by Alcian blue 
staining of HS extracted from EBV-transformed B cells and 
fractionated by 5–12% gradient SDS-PAGE (Fig. 2 B). Fur-
thermore, extracted ion chromatogram liquid chromatogra-
phy–mass spectrometry revealed an abnormal HS sulfation 
pattern in P1’s fibroblasts, with increase in 6-O–sulfated and 
2-O–sulfated disaccharides, which was corrected by EXTL3 
overexpression upon transduction of P1’s fibroblasts with a 
lentiviral vector encoding for a wild-type copy of EXTL3 
cDNA (Fig. 2, A and C). Increase in 6-O–sulfated disaccha-
rides and longer HS chains have been previously demonstrated 
upon siRNA-mediated silencing of EXTL3 in HEK-293 
(Busse et al., 2007). Altogether, these results indicate that the 
EXTL3 R339W mutation is a hypomorphic allele that alters 
the function of the enzyme and leads to longer HS chains 
with an aberrant sulfation pattern.
Abnormalities of intracellular 
signaling in EXtL3-mutated cells
All three patients presented clinical and radiographical features 
that were reminiscent of those associated with FGFR mutations 
causing increased intracellular signaling (Tavormina et al., 1995). 
Longer HS chains containing an increased amount of 6-O 
sulfates have been previously shown to provide an additional 
binding site for FGFR, increasing FGF signaling (Sugaya et al., 
2008; El Masri et al., 2016). As compared with control-derived 
fibroblasts, P1’s cells showed increased extracellular signal–reg-
ulated kinase (ERK) phosphorylation upon FGF2 stimulation, 
and this abnormality was corrected by overexpression of wild-
type EXTL3 (Fig. 2 D). These results indicate that by altering 
HS chain length and composition, EXTL3 mutations potentiate 
FGF2 signaling, thereby contributing to the pathophysiology of 
the skeletal dysplasia observed in the patients.
HS plays an important role also in regulating signaling 
in response to various cytokines, including IL-2 (Wrenshall 
et al., 2003) and IL-7 (Milne et al., 2008). Upon stimulation 
of PBMCs from P3 and a healthy control with various cyto-
kines, we observed marked reduction of STAT5 phosphory-
lation in P3’s PBMCs in response to IL-2, with a more subtle 
defect in response to IL-7 (Fig. 2 E).
extl3-mutant zebrafish have defective thymopoiesis
Abnormalities of cartilage development and defective 
pectoral fin formation had been previously reported in extl3-
mutant zebrafish (box; Schilling et al., 1996; van Eeden et al., 
1996; Lee et al., 2004; Norton et al., 2005) and confirmed 
by us (Fig. 3 A), but no information was available on thymic 
development in the mutant fish. To investigate this, we 
crossed extl3/box zebrafish with Tg(rag2 :gfp) transgenic 
zebrafish (Jessen et al., 2001) and analyzed expression of 
the GFP to visualize the thymus in developing embryos 
(Langenau et al., 2004). In-vivo immunofluorescence 
analysis revealed a decreased GFP signal in mutant animals 
compared with siblings (Fig.  3  B), and confocal imaging 
followed by isosurface three-dimensional (3D) reconstruction 
demonstrated a 50% decrease in the volume occupied by 
GFP+ cells (Fig.  3, C and D). To prove that the defect is 
caused by the extl3 mutation, we injected mutant and sibling 
zygotes with wild-type human EXTL3 mRNA and observed 
rescue of the thymic phenotype (Fig.  3  E). Normalization 
of pectoral fin development was also achieved (Fig. 3 E), as 
previously reported, with injection of wild-type zebrafish 
extl3 mRNA (Lee et al., 2004). The EXTL3 protein may also 
serve as a receptor for the regenerating (REG) protein family, 
functioning independently from HS production (Levetan et 
al., 2008; Acquatella-Tran Van Ba et al., 2012; Lai et al., 2012). 
To dissect which of these two functions of EXTL3 has a role 
in thymocyte development, we studied the dakto273-mutant 
zebrafish, which carries a null mutation in ext2, associated 
with severe reduction in HS production (Lee et al., 2004) 
and abnormalities of fin and branchial arch development 
(Fig. 3 F). EXT2 is involved in HS biosynthesis (McCormick 
et al., 2000; Senay et al., 2000) but has no known role in REG 
protein signaling. A marked decrease of thymus volume was 
also observed in ext2/dak Tg(rag2 :gfp) zebrafish (Fig.  5, G 
and H), providing definitive evidence in vivo that HS plays an 
important role in thymopoiesis.
Patient-derived induced pluripotent stem cell (iPScs) have 
reduced ability to generate lymphoid progenitor cells and  
to differentiate to thymic epithelial progenitor (tEP) cells
HS modulates the activity of morphogens and growth fac-
tors involved in mesodermal and hematopoietic progenitor 
cell (HPC) differentiation (Holley et al., 2011; Kraushaar 
et al., 2012) and in expansion and maturation of lymphoid 
progenitor cells (Borghesi et al., 1999). To gain insights into 
the pathophysiology of impaired T cell development in pa-
tients with EXTL3 deficiency, we generated iPSCs from 
root with full cheeks (C). (D–L) Radiographs show short metacarpals and phalanges, open iliac wings, narrow sacro-ischiatic notches, radiolucent band at 
proximal femurs reminiscent of achondroplasia, and severe diffuse platyspondyly with expanded intervertebral spaces. In the pelvis of P3, there is coxa 
valga with delayed ossification of femoral heads, acetabular dysplasia, and hip subluxation. (D–F) P1; (G–I) P2; (J–L) P3. All radiographs were taken at birth, 
except for the pelvis of P3 (K), which was taken at 2 yr and 5 mo. (M) Laboratory data at diagnosis. ALC, absolute lymphocyte count. (N) Chromatograms 
demonstrating homozygosity for EXTL3 mutations in the affected patients. (O) Evolutionary conservation of the EXTL3 protein in the region containing the 
mutations detected in patients.
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Figure 2. EXtL3 mutations affect HS composition and cell signaling. (A, left) Western blot analysis of EXTL3 protein expression in fibroblasts from 
a control and P1 and in P1’s fibroblasts complemented with a lentiviral vector–expressing wild-type EXTL3 (P1 LV). (Right) Western blot analysis of EXTL3 
protein expression in PBMCs from a control and P3. β-actin was used as a loading control. Shown is a representative image of n = 3 experiments. (B, left) 
Alcian blue staining of HS length in EBV-B cell lines from control (C) and P1, as assessed by 5–12% SDS-PAGE. (Right) Relative quantification of content of 
HS’s of various length (defined by regions of interest; boxes on the left) in P1 versus control. Shown is the mean ± SD from one representative experiment 
of two. (C) Disaccharide composition analysis of HS chains, showing an increase in 6-O–sulfated and 2-O–sulfated disaccharides (peaks 4 and 5) in P1 
cells, which was corrected by complementation with P1 LV. Shown are representative images of n = 2 experiments. (D, top) Western blot analysis of ERK 
phosphorylation (p44/42) at 0, 15, and 30 min after FGF2 stimulation of control, P1, and P1 LV fibroblasts. Shown is a representative image from three (P1 
LV) and five (control and P1) replicates. (Bottom) Relative quantification (RQ) of the ratio between phospho-p44/42 and total p44/42 signal in stimulated 
versus unstimulated conditions. Shown is the mean ± SD from the same experiments as in the top panel. Statistical significance was assessed with two-
tail Student’s t tests. (E) Overlays of flow cytometry histograms of phospho-STAT5 (pSTAT5) signal in unstimulated (tinted) and cytokine-stimulated (solid) 
PBMCs from a healthy control and P3. Gating was on CD4+ cells. Shown is one representative experiment of two.
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P1 and from a healthy control (Fig.  4, A–C) and differen-
tiated them toward HPCs and T lymphocytes (Brauer et al., 
2016). Patient-derived iPSCs manifested a defect in embryoid 
body size and cell number and exhibited impaired expan-
sion of HPCs (Fig. 4 D). A similar phenotype was previously 
reported during in vitro differentiation of Ext1−/− mouse 
Figure 3. extl3/box-mutant zebrafish has defective thymopoiesis that is rescued by injection of EXtL3 wild-type rnA. (A) Extl3/box-mutant 
fish have shorter pectoral fins (arrows). (B) Immunofluorescence image of RAG2-GFP expression in 6–d postinfection (dpf) extl3/box Tg(rag2 :gfp) larvae. 
Arrows indicate the thymus. (C and D) Representative images of isosurface 3D reconstruction (C) and total volume quantification (D) of thymic GFP signal 
from 6-dpf extl3/box Tg(rag2 :gfp) larvae. (A–D) Shown are representative data of >50 sibling (sib) and 30 box animals from three independent experiments. 
(E) Rescue of thymic volume (left) and pectoral fin length (right) in 6-dpf extl3/box Tg(rag2 :gfp) larvae injected with 100 ng EXTL3 wild-type RNA. Relative 
fin length indicates the ratio between lengths of fin to eye. n = 2 experiments. Error bars represent SEM. (F) Ext2/dak-mutant fish have shorter pectoral fins. 
(G and H) Representative images of isosurface 3D reconstruction (G) and total volume quantification (H) of thymic GFP signal from 6-dpf ext2/dak Tg(rag2 
:gfp) larvae. (F–H) Shown are representative images of >50 sibling, 30 box, and 27 dak animals from three independent experiments. Statistical significance 
was assessed using two-tail unpaired Student’s t test (D) and one-way ANO VA with Bonferroni post-analysis (E and H).
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embryonic stem cells to embryoid bodies and hemangioblasts 
(Holley et al., 2011; Kraushaar et al., 2012). Upon co-culture 
on OP9-DL4 stromal cells, expansion of EXTL3-deficient 
cells was greatly diminished (Fig. 4 E); however, expression of 
markers indicative of  T cell lineage commitment and matura-
tion was preserved (Fig. 4 F). These data indicate that EXTL3 
plays a critical role in the expansion of HPCs but may not 
be required at later stages of  T cell differentiation, although 
a possible compensatory role of HS provided in trans by the 
OP9-DL4 cells in this system cannot be excluded.
By modulating FGF signaling, HSPG also regulates the 
differentiation and proliferation of TECs (Anderson and Jen-
kinson, 2001; Revest et al., 2001b; Rodewald, 2008). In the 
human thymus, TECs express EXTL3 at higher levels than 
hematopoietic cells (Fig. 5 A). To address whether EXTL3 
mutations affect TEC differentiation, we applied to human 
iPSCs a protocol used to induce differentiation of human 
embryonic stem cells to definitive endoderm (DE), ventral 
pharyngeal endoderm, and TEP cells (Parent et al., 2013). 
Timely regulated exposure to a defined set of developmental 
cues (Fig. 5 B) allowed progressive differentiation of control- 
derived iPSCs, with differential expression of genes that 
mark DE, ventral pharyngeal endoderm, and TEP stages 
(Fig. 5 C). At the end of the culture, confocal microscopy 
demonstrated coexpression of cytokeratin 8 (CK8) and CK5 
and nuclear expression of FOXN1 (Fig. 5 D), confirming 
the TEP phenotype (Parent et al., 2013; Sun et al., 2013; 
Su et al., 2015). Comparative analysis of gene expression 
by quantitative PCR at the TEP stage demonstrated that 
EXTL3-mutated cells had decreased expression of TBX1, 
EYA1, and CK5, as compared with control-derived cells, 
and a similar trend was observed for FOXN1 (Fig.  5  E). 
In contrast, EXTL3-mutated cells retained high levels of 
SOX17 expression, which in control cells reaches a peak 
of expression at the DE stage and is then down-regulated. 
Altogether, these data indicate that EXTL3 deficiency also 
affects TEC differentiation.
In summary, our results show that EXTL3 mutations in 
humans cause abnormalities of HS length and composition 
that alter cellular responses and result in T cell immunode-
ficiency, skeletal dysplasia, and neurological complications. 
Future studies may clarify whether the spontaneous improve-
ment of T cell count in P3 is part of the natural history of the 
disease or expression of a milder phenotype. Finally, this study 
expands the number of SCID-related disorders that can be 
identified with newborn screening.
MAtErIALS And MEtHodS
case studies
P1 and P2 were siblings born to parents of North African 
descent from the same village of Tunisia. The older patient 
(P1) was born at term by C-section because of severe fetal 
distress. P1’s weight was 2,315 kg (less than third percentile), 
length was 48 cm (10th percentile), and head circumference 
was 35 cm (50th percentile). Short limbs and scaphocephaly 
were apparent. Mechanical ventilation was necessary because 
of respiratory distress. Laryngotracheal narrowing was found 
on laryngeal endoscopy, abdominal sonography revealed the 
presence of multiple liver cysts, and craniocervical magnetic 
resonance imaging showed impingement of the posterior 
arch of C1 on the medulla with mild stenosis of the cervical 
canal requiring neurosurgery. Over the first months of life, 
short-limbed dwarfism (length at age 4 mo less than third 
percentile) became evident. The patient developed Klebsiella 
and Staphylococcus aureus sepsis at 3 mo and generalized ex-
foliating dermatitis at 5 mo (Fig. 1 A). Immunological eval-
uation at that time demonstrated that >97% of circulating 
CD4+ and CD8+ cells had an activated/memory (CD45RA−) 
phenotype. Maternal T cell engraftment was ruled out by mi-
crosatellite analysis, and oligoclonality of circulating T cells 
was demonstrated by heteroduplex analysis of T cell recep-
tor β variable (TCR BV) gene rearrangement PCR products. 
TCR excision circles (TRECs) at that time were undetect-
able (normal value: >41/µl). Neurological abnormalities 
included opisthotonus with generalized hyperreflexia, gener-
alized seizures, and absence of any interaction with the envi-
ronment. The infant deceased at 11 mo of age after a history 
of recurrent infections. 
A younger sister (P2) was born at gestational week 37 
by C-section because of signs of fetal distress. She also pre-
sented with respiratory distress; short limbs were apparent, as 
was a cloverleaf skull deformity (Fig. 1 B); there was also anal 
atresia, for which a colostomy was performed in the first days 
of life. Imaging studies revealed the presence of multiple pre-
mature craniosynostoses, a malformation of the craniocervical 
junction with narrowing of the cervical canal and a thin cord, 
and the presence of multiple liver cysts. Clonic arm move-
ments and nystagmus were interpreted as seizure equivalents, 
and developmental delay was ascertained. After multiple in-
fections and seizures, the patient died at 7 mo of age. TREC 
and control genomic DNA were quantitated from the recov-
ered newborn dried blood spots of P2 and a control infant 
born the same day; whereas both samples had detectable actin 
control copies (though lower than in samples stored desic-
cated at –20°C), TRECs were present in the control DNA 
but absent in DNA from P2.
The third patient (P3), a Hispanic female, was born at 
term by spontaneous vaginal delivery to a G5P3-4, with a 
birth weight of 2,405 g (less than third percentile). There 
was no known consanguinity, and the family history was 
negative for other affected relatives. She was ascertained 
after positive newborn screening for SCID (T cell exci-
sion circles, TRECs of 12/µL blood, with the normal range 
being >25/µL; control actin copy number was normal). In 
addition, she had marked skeletal dysplasia and developmen-
tal delay. Her facial features (Fig. 1 C) demonstrated hypoto-
nia and long and up-slanting palpebral fissures, simple ears, 
and a small chin. She had wide-spaced nipples and a pectus 
excavatum, short limbs with extra skin folds at the shoulders 
and elbows, a severe thoracic scoliosis and lumbar lordosis, 
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Figure 4. Altered HPc expansion from EXtL3 r339W iPScs. (A and B) Morphological appearance (A) and immunofluorescence analysis (B) of P1’s 
iPSCs. Shown are results for one representative iPSC clone of three that were tested. (C) Quantitative real-time PCR analysis of expression of pluripotency 
markers in patient and control iPSCs versus parental fibroblasts. Shown are results from one representative experiment of three. (D) Count of HPCs formed 
during embryoid body differentiation. Shown are mean values ± SEM from two independent experiments with three different iPSC clones for both control 
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a left single transverse crease, brachydactyly of the halluces 
and fifth toes, and two elbow dimples bilaterally. Her tone 
was markedly reduced, but there were no other neurological 
findings. In her first year of life, she had severe failure to 
thrive and required high calorie supplements and tube feed-
ings with a G-tube. Metabolic assessment demonstrated hy-
pertriglyceridemia. A magnetic resonance image of the brain 
and spine at 8 mo of age showed platyspondyly, lordosco-
liosis, and pear-shaped vertebral ossification. No vertebral 
segmentation defects were identified. She had hypoplasia of 
the posterior C1 arch with narrowing of the cervical spi-
nal canal and cord compression requiring neurosurgery. She 
was diagnosed with esotropia and chronic blepharitis with 
recurrent bilateral chalazion. Radiographs of the spine at 2 
yr of age confirmed platyspondyly of the lower thoracic and 
lumbar spine with increased loss of vertebral height com-
pared with disc spaces and progression of the thoracolumbar 
kyphosis to 90 degrees. A pelvic radiograph showed bilateral 
coxa vara, dysplastic changes of both hips, and subluxation 
of the left hip. When last examined at 2 yr and 5 mo of age, 
she was able to reach for objects, roll over, sit with sup-
port, and had several single words. Her height was 74 cm 
(−4.18 SD), her weight was 7.173 kg (−6.84 SD), and her 
head circumference was 46 cm (–1.87 SD). Spontaneous, 
partial improvement of immune function was observed at 
1 yr and 4 mo of life. At that time, administration of intra-
venous immunoglobulins was suspended, and production of 
specific antibodies was observed in response to both killed/
recombinant and live vaccines. At the time of last evalua-
tion (2 yr and 7 mo), T cell counts were as follows: CD3+, 
1,317 cells/µl (normal values: 1,400–3,700); CD4+, 817 
cells/µl (of which 43% were naive; normal values: 53–86); 
and CD8+, 545 cells/µl (of which 43.2% were naive; nor-
mal values 69–97). No evidence of somatic gene reversion 
was found upon high throughout sequencing of the EXTL3 
locus around position c.1382 in P3’s T cell blasts.
Genetic analysis
All studies performed were approved by the institutional ethi-
cal review boards of Gaslini Children’s Hospital, Boston Chil-
dren’s Hospital, and University of California, San Francisco. 
Informed consent was obtained from the patients’ parents.
For P1 and P2, fragmented genomic DNA was pu-
rified with AMPure XP beads, and its quality was assessed 
with a Bioanalyzer (2100; Agilent Technologies). Sequenc-
ing libraries were generated using the SureSelect Human 
All Exon kit (v4; Agilent Technologies). The final libraries 
were quantified with a Qubit Fluorometer (Thermo Fisher 
Scientific), and the correct size distribution was validated 
on the Bioanalyzer (2100). Libraries were sequenced on 
a sequencing system (HiSeq 2000; Illumina) generating 
100-bp paired-end reads. Raw reads were aligned onto 
the hg19 reference genome using NovoAlign (Novacraft 
Technologies). Data cleanup and variant calling were per-
formed according to the Genome Analysis Toolkit Best 
Practices recommendations (Van der Auwera et al., 2013). 
Variant filtering was made with ANN OVAR (Wang et al., 
2010) and with in-house perl and bash scripts, available 
upon request. Homozygosity mapping was achieved by 
the use of Homozygosity Mapper software (Seelow et al., 
2009) on the merged vcf file of P1, P2, and parents. A com-
parison was made between the two affected siblings (cases) 
and the parents (controls) to detect region of autozygos-
ity shared by the two affected siblings only. For P3, WES 
was performed at the University of California, Los Angeles 
Clinical Genomics Center, as described previously (Lee et 
al., 2014). Sanger sequencing was performed on genomic 
DNA extracted from fibroblasts (P1) or EBV-B cell lines 
(P2 and P3) using primer sequences and PCR conditions 
that are available upon request.
Western blot analysis of EXtL3 expression
Protein lysates were obtained from fibroblasts from a healthy 
control and P1, P1 cells complemented with a lentivirus 
(LV) vector expressing wild-type EXTL3 cDNA (P1 LV), 
and PBMCs from a healthy donor and P3, upon lysing 
cells in SDS sample buffer. Protein lysates were separated 
by 4–12% gradient SDS-PAGE, transferred onto nitrocel-
lulose using an iBlot2 system (Thermo Fisher Scientific), 
and immunoblotted with anti-EXTL3 rabbit polyclonal 
antibody (Ab113063; Abcam) and anti–β-actin mAb (Cell 
Signaling Technology), followed by staining with second-
ary donkey anti–rabbit IgG HRP-conjugated antibody 
and HRP-conjugated sheep anti–mouse IgG (both from 
GE Healthcare). The blot was developed with SuperSig-
nal West Femto substrate for EXTL3 and SuperSignal 
West Dura substrate for β-actin (both from Thermo Fisher 
Scientific). Bands were visualized using Omega Lum C 
Imager and software (Aplegen).
HS isolation, SdS-PAGE gradient,  
and disaccharide composition analysis
Proteoglycans were extracted from cell pellets by 7 M urea 
in PBS, pH 7.4, at 4°C with gentle stirring and isolated by 
diethylaminoethyl-Sepharose chromatography. To isolate 
HS, the total proteoglycan preparation was incubated with 
chondroitinase ABC (Seikagaku) followed by proteinase K, 
and samples were separated by diethylaminoethyl chromatog-
and P1. (E) Cell count of lymphoid precursors at different time points of OP9-DL4 T cell differentiation assay. Represented are means of two experiments 
from three different iPSC clones. Error bars represent SEM. (F) Normal surface expression of CD4 and CD8 molecules at late stages of OP9-DL4 T cell differ-
entiation assay. Representative figures of two experiments from three different iPSC clones are shown. Statistical significance was assessed using two-tail 
unpaired Student’s t test (D) or two-way ANO VA (E).
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raphy. Bound materials were eluted by 2 M NaCl, dialyzed 
against autoclaved deionized water, and concentrated by lyo-
philization. The amount of HS was measured by the carbazole 
method (Bitter and Muir, 1962). 25 µg of the isolated HS 
were lyophilized, digested with heparinase I, II, and III, and 
then analyzed by extracted ion chromatogram liquid chro-
matography–mass spectrometry. To estimate the approximate 
size of total glycosaminoglycans and HS, 5 µg of each sample 
were fractionated by 5–12% gradient SDS-PAGE and visual-
ized by Alcian blue staining.
Figure 5. Altered tEP cell differentiation from EXtL3-mutant iPScs. (A) Flow cytometric analysis of EXTL3 expression in total human thymic 
epithelial cell adhesion molecule (EpCam)+ TECs and CD45+ hematopoietic cells. FMO, fluorescence minus one. One representative experiment of two is 
shown. (B) Scheme of TEP differentiation protocol. (C) Gene expression profile during differentiation of control-derived iPSCs. (D) Immunofluorescence 
analysis of epithelial markers at TEP stage differentiation of control-derived iPSCs. (E) Differences in gene expression between control and P1 iPSC–de-
rived TEPs. (C–E) Shown are representative results of at least three experiments, in each of which two different iPSC clones were tested for both P1 and 
healthy donor. Error bars represent SEM. iPS, iPSC; RA, retinoic acid; VPE, ventral pharyngeal endoderm. Statistical significance was assessed using two-tail 
unpaired Student’s t test.
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Intracellular signaling in response to FGF-2 and cytokines
Fibroblasts from a healthy control, P1, and P1 LV fibroblasts 
were serum starved for 2 h and then stimulated in the presence 
or absence of 100 ng/ml human FGF-2 in DMEM. After 15 or 
30 min, cells were lysed in SDS sample buffer. Protein lysates 
were separated by 5–15% gradient SDS-PAGE, transferred 
onto nitrocellulose membrane, and immunoblotted with rab-
bit anti-phospho ERK1/2 (Cell Signaling Technology) and 
HRP-conjugated donkey anti–rabbit IgG (BioLegend).
For the analysis of STAT5 phosphorylation in re-
sponse to cytokines, PBMCs from two healthy controls and 
P3 were cultured in 96-well round-bottom plates (200,000 
cells/well) in the presence of 10 ng/ml IL-2 or 10 ng/ml 
IL-7, in RPMI medium, 10% FBS, and APC-conjugated an-
ti-CD4 mAb at 37°C and 5% CO2 for 20 min. After wash-
ing, cells were permeabilized with Cytofix (BD) at 37°C 
for 10 min and then washed and stained with Pacific blue–
conjugated anti-pSTAT5 (BD). The cells were washed, and 
pSTAT5 expression was analyzed by flow cytometry upon 
gating on live CD4+ cells.
Analysis of EXtL3 expression in human thymus
Human thymus samples were collected from pediatric pa-
tients undergoing cardiac surgery (under the clinical proto-
col TIG ET07, approved by the Ethical Committee of San 
Raffaele Scientific Institute). Thymic tissue was cleaned 
and minced into small pieces before digestion with Liber-
ase/DNase I (Sigma-Aldrich). Digested tissue was depleted 
of CD45-positive cells using the AutoMACS Pro separator 
(Miltenyi Biotec) after incubation with anti–human CD45 
microbeads (Miltenyi Biotec). After depletion, thymic cells 
were stained with antibodies anti–human CD45 APC, ep-
ithelial cell adhesion molecule/CD326 Pe-Vio770, HLA 
DR PE, CD31 APC-Vio770 (all from Miltenyi Biotec), and 
Ulex europaeus agglutinin I FITC (UEA I FITC; Vector 
Laboratories). After surface staining, thymic cells were fixed/
permeabilized (Foxp3 Staining Buffer set; eBioscience) and 
stained intracellularly with anti-Extl3 antibody (Ab113063; 
Abcam), followed by a secondary goat anti–rabbit IgG Alexa 
Fluor 405 antibody (Invitrogen). Then, cells were acquired 
on a FACS Canto II cell analyzer (BD) and analyzed using 
FlowJo software (Tree Star).
Zebrafish studies
Zebrafish were maintained in accordance with Animal 
Research Guidelines at Boston Children’s Hospital. The 
extl3 (boxtm70g) and ext2 (dakto273) mutants and Tg(rag2 
:GFP) transgenic zebrafish used in this study were previously 
described (Jessen et al., 2001; Lee et al., 2004).
For live imaging, zebrafish embryos were mounted in 
0.8% low–melting point agarose or 4% methylcellulose con-
taining 160 mg/L tricaine as previously described (Bertrand 
et al., 2010). Images were taken using a dissection stereoscopic 
microscope (Stereo Discovery V8; ZEI SS) with a 0.63× ob-
jective and 8.3× optical zoom. To determine thymic volume, 
embryos were mounted in 0.8% low melting point agarose, 
and Z stacks of 25 sections every 2 µm, 512 × 512 pixels im-
ages (pixel size of 0.33 µm), were recorded using an upright 
microscope (C2si confocal NiE; Nikon) with a 25× objec-
tive. Image processing was done with NIS elements software 
(Nikon). Image post-processing and thymus isosurface anal-
ysis and quantification were done with Imaris software (Bit-
plane). Quantification of fin length in each fish was made by 
measuring the lengths of fin and eye in photographic images 
at a magnification of 8.3. For normalization, values were ex-
pressed as the ratio between lengths of fin to eye. For rescue 
experiments, full-length human EXTL3 and EXTL3 R339W 
cDNA were subcloned into the pCS2+ expression vector. 
mRNA from both sequence-verified constructs was tran-
scribed in vitro after NotI linearization, using the SP6 mMES 
SAGE mMAC HINE kit (Ambion). For mRNA injections, 
100 pg EXTL3 or EXTL3 R339W mRNA was injected into 
the yolk of first–cell stage embryos. Embryos were analyzed 
for thymic volume or pectoral fin length at 6 d after fertiliza-
tion and genotyped by PCR (primer sequences are available 
upon request), followed by EcoRV restriction digestion.
iPSc derivation, maintenance, and differentiation
Primary fibroblasts from P1 were reprogrammed to iPSCs by 
infection with a nonintegrating CytoTune Sendai viral vector 
kit (Thermo Fisher Scientific). Primary fibroblasts were plated 
in 12-well dishes at 50–80% confluency and transduced with 
the recombinant vectors according to the manufacturer’s pro-
tocol. The medium was changed after 24 h of infection, and 
the cells were allowed to grow for 6 d. On day 7, the cells 
were replated onto γ-irradiated CF-1 mouse embryonic fi-
broblast (MEF) feeder cells (EMD Millipore) in DMEM/F12 
medium containing 1% penicillin/streptomycin, 1% l-gluta-
mine, 20% knockout serum replacement (KSR), 1% nones-
sential amino acids, and 100 µM β-mercaptoethanol (Thermo 
Fisher Scientific), supplemented with 10% MEF-conditioned 
medium (iPSC medium) on day 8, and the cells were cultured 
until colonies formed. iPSCs were selected based on mor-
phology, subcloned for five to seven passages, manually picked 
as single-colony cells, seeded into wells of a 96-well plate 
containing 8.5 × 103 irradiated MEFs per well in standard 
human embryonic stem cell medium, and cultured at 37°C 
and 5% CO2. Analysis of the stemness and pluripotency pro-
file was performed by immunofluorescence and quantitative 
real-time PCR, as previously described (Rissone et al., 2015). 
For immunofluorescence staining, cells were washed with 
PBS, fixed at room temperature in 4% paraformaldehyde/
PBS for 15 min, washed with PBS, permeabilized/blocked 
for 1 h at room temperature using 0.1% Triton X-100 in ani-
mal-free blocker (Vector Laboratories) followed by three PBS 
washes, then stained with fluorochrome-labeled antibodies 
against OCT-4, NAN OG, SSEA4, and TRA-1-60, and coun-
terstained with Hoechst 33342. Expression of stemness mark-
ers was assessed upon imaging with a Pathway 435 bioimager 
(BD) using a 10× lens. For quantitative real-time PCR, RNA 
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was extracted from 106 cells using the mirVana RNA isolation 
kit (Ambion) and reverse transcribed to cDNA with qScript 
cDNA supermix (Quanta Bioscience), according to the man-
ufacturer’s instructions. Expression of the OCT4, NAN OG, 
SOX2, KLF4, cMYC, ABCG2, DNMT3B, and GDF3 genes 
was quantified by real-time PCR with Power SYBR Green 
PCR master mix (Applied Biosystems) on a Real Time PCR 
analyzer (7500; Applied Biosystems) and normalized to the 
human β-actin (hACTB) gene expression using primers pre-
viously reported (Park et al., 2008). Relative expression com-
pared with parental fibroblasts was calculated using the ΔΔCt 
method. Colonies with a robust stemness and pluripotency 
profile were assessed for karyotypic integrity by G-banding.
Embryoid body (EB) generation and cd34+ cell isolation
Differentiation of iPSCs was performed in serum-free me-
dium (StemPro-34; Thermo Fisher Scientific) containing 50 
µg/ml l–ascorbic acid, 2 mM l-glutamine, 150 µg/ml trans-
ferrin, 0.45  µM monothioglycerol, and various cytokines 
and growth factors at 37°C, 5% O2, and 5% CO2, as previ-
ously described (Kennedy et al., 2012). iPSCs were feeder 
depleted on tissue-culture plates coated with Matrigel (BD) 
for 1 d. iPSC aggregates were transferred to ultra lo-attach-
ment 6-well plates (Corning) containing cytokines, growth 
factors, and inhibitors for induction of differentiation toward 
definitive hematopoiesis. Cytokine and growth factor addi-
tion was as follows for embryoid body differentiation: days 
0–3, 10 ng/ml BMP4; days 1–8, 10 ng/ml basic FGF; days 
1.75–3, 5 µM SB-431542; days 4–8, 15 ng/ml vascular en-
dothelial growth factor, 10 ng/ml IL-6, and 5 ng/ml IL-11; 
and day 6–8: 2 U/ml erythropoietin, 25 ng/ml IGF1, and 50 
ng/ml stem cell factor.
After 8 d of differentiation, embryoid bodies were dis-
sociated into single cells as previously described (Kennedy 
et al., 2012), stained with anti-CD34 PE-conjugated anti-
body (BD), followed by anti-PE–conjugated microbeads, and 
positively selected using a magnetic-activated cell-sorting 
(MACS) column (Miltenyi Biotec) as per the manufactur-
er’s instructions. Cell yield and purity were assessed pre– and 
post–MACS purification by flow cytometry.
co-culture with oP9-dL4 cells and in 
vitro t cell differentiation
OP9-DL4 cells were cultured in α-MEM containing 20% 
FBS (lot no. 1140803), 1% penicillin/streptomycin (Thermo 
Fisher Scientific), and phospho–ascorbic acid (Sigma-Al-
drich) at 37°C and 5% CO2. For co-culture, OP9-DL4 cells 
were plated in 6-well plates the previous day.
MACS-purified CD34+ cells were counted and seeded 
at a density of 200,000–250,000 cells per well on a 6-well 
plate and differentiated toward the T cell lineage by co-cul-
ture with OP9-DL4 cells in OP9 medium containing 5 ng/
ml recombinant human IL-7, 5 ng/ml recombinant human 
FLT3L, and 10 ng/ml recombinant human stem cell factor 
(Miltenyi Biotec) at 37°C and 5% CO2, and T cell progen-
itors were passaged and co-cultured with fresh OP9-DL4 
cells approximately every 5 d, as previously described (La 
Motte-Mohs et al., 2005).
At various time points during co-culture of iPSC-de-
rived cells on OP9-DL4 stromal cells, analysis of the expres-
sion of T cell markers was performed. Cells were stained for 
30 min on ice with combinations of the following mouse 
anti–human antibodies: CD3–Brilliant Violet 421, CD4–
Alexa Fluor 700, CD8b-PE, CD31-FITC, CD34-PE, 
CD45RA-PE/CF594, TCRγδ-FITC (BD), CD5-PE/Cy7, 
CD7–Alexa Fluor 700, CD45-PC/eFluor780, TCRαβ-APC 
(eBioscience), CD8α-PE/Dazzle, and CD38–Brilliant Vi-
olet 421 (BioLegend). Cells were resuspended in flow cy-
tometry buffer containing DAPI. Data were collected using 
an LSR Fortessa flow cytometer (BD) and analyzed using 
FlowJo (version 9.7.6).
differentiation to tEP cells
Undifferentiated iPSCs were maintained on γ-irradiated 
MEFs and mechanically split by needle for passage. For differ-
entiation, iPSCs were transferred to Corning Matrigel human 
epithelia stem cell–qualified Matrix-coated plates. After four 
to five passages, the cells were plated on the Matrigel-coated 
24-well plates at a density of 2.5 × 105 cells/cm2 and differ-
entiated 24 h later. TEP differentiation protocol was based on 
a protocol by Parent et al. (2013) with minor modifications. 
During days 1–5 (d1–d5), differentiation was performed in 
RPMI 1640 media (Invitrogen) supplemented with 1% pen-
icillin/streptomycin, 1% of l-glutamine, and increasing con-
centrations of KSR (0% on d1, 0.2% on d2–d3, and 2% on 
d4–d5). For d6–d14, cells were differentiated in DMEM/
F12 with 1% penicillin/streptomycin, 1% l-glutamine, and 
0.5% B-27 supplement (50×) serum-free medium (Thermo 
Fisher Scientific). The following factors were added: activin 
A, 100 ng/ml (d1–d5); Wnt3a, 25 ng/ml (d1) or 50 ng/ml 
(d8–d14); all-trans retinoic acid, 0.25 µM (d6–d8) or 0.1 µM 
(d9–d14); BMP4, 50 ng/ml (d6–d14); LY364947, 5 mM (d6–
d9); FGF8b, 50 ng/ml (d8–d14); and KAAD-cyclopamine, 
0.5 mM (d8–d14). Supplements and factors were from In-
vitrogen (B27 and KSR), R&D Systems (activin A, Wnt3a, 
BMP4, and FGF8b), Sigma-Aldrich (retinoic acid), and EMD 
Millipore (KAAD-cyclopamine and LY364947).
For the analysis of gene expression during differentiation 
of iPSCs to TEPs, at time points reported in Fig. 5 B, total RNA 
was isolated from by an RNeasy kit (QIA GEN), and cDNA 
was synthesized by a qScript cDNA Synthesis kit (Quanta Bio-
sciences) according to the manufacturer’s protocol. Real-time 
quantitative PCR was performed on a real-time PCR system 
(7500; Applied Biosystems) using PerfeCTa SYBR Green Fast-
Mix, Low ROX (Quanta Biosciences). After normalization to 
the housekeeping gene TATA-binding protein (TBP) gene 
TBP, for each sample, ΔΔCt values of gene expression were 
calculated relative to levels in undifferentiated control iPSCs.
Quantitative PCR primers for TBP, HOXA3, EYA1, 
and FOXN1 were as previously published (Parent et al., 2013). 
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Other primers were as follows: SOX17 forward, 5′-GGC 
GCA GCA GAA TCC AGA-3′ and reverse, 5′-CCA CGA CTT 
GCC CAG CAT-3′; CK5 forward, 5′-TCT CGC CAG TCA 
AGT GTG TC-3′ and reverse, 5′-ATA GCC ACC CAC TCC 
ACA AG-3′; CK8 forward, 5′-TCA TCA AGA AGG ATG 
TGG ATG-3′ and reverse, 5′-ACC ACA GAT GTG TCC GAG 
AT-3′; and TBX1 forward, 5′-ACG CCT TCC ACA GCT 
CCT-3′ and reverse, 5′-CGC TAT CTT TGC GTG GGTC-3′.
For confocal microscopy analysis, cells cultured in 24-
well plates were fixed for 30 min in 4% paraformaldehyde 
with PBS at room temperature, washed twice in PBS, and 
then blocked for 1 h in 10% donkey serum and 0.1% Triton 
X with PBS at room temperature. Cells were incubated over-
night at 4°C with the appropriate primary antibodies diluted 
in PBS and then incubated for 1 h at room temperature in the 
dark with secondary antibodies diluted in PBS. Nuclei were 
counterstained with DAPI. Images were taken with a spinning 
disk confocal microscope (UltraVIEW VoX; PerkinElmer).
The primary antibodies used were as follows: anti-CK5 
(catalog no. ab24647; Abcam), anti-CK8 (catalog no. ab2530; 
Abcam), and rabbit anti-FOXN1 (catalog no. bs-6970R; 
Bioss). Secondary antibodies were Alexa Fluor 488–conju-
gated donkey anti–mouse IgG H and L (catalog no. ab150105; 
Abcam) and Alexa Fluor 594–conjugated donkey F(ab’)2 
anti–rabbit IgG H and L (catalog no. ab150072; Abcam).
online supplemental material
Fig. S1 shows a summary of the analysis of WES data in the 
affected patients and their respective parents. Tables S1 and S2 
show the genetic variants compatible with causing disease in 
the two families analyzed.
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